Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8399909rdf:typepubmed:Citationlld:pubmed
pubmed-article:8399909lifeskim:mentionsumls-concept:C0024671lld:lifeskim
pubmed-article:8399909lifeskim:mentionsumls-concept:C0026944lld:lifeskim
pubmed-article:8399909lifeskim:mentionsumls-concept:C0317824lld:lifeskim
pubmed-article:8399909lifeskim:mentionsumls-concept:C0206527lld:lifeskim
pubmed-article:8399909lifeskim:mentionsumls-concept:C1963758lld:lifeskim
pubmed-article:8399909lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8399909pubmed:dateCreated1993-11-9lld:pubmed
pubmed-article:8399909pubmed:abstractTextMycoplasma arthritidis produces a potent superantigen (MAM) that activates specific murine and human T lymphocytes to proliferate and secrete lymphokines. We show here that MAM also influences both T- and B-cell functions in vivo. Lymphocytes from mice injected with MAM exhibit a suppression of proliferative responses to MAM in vitro but only a partial suppression of responses to other mitogens. This T-cell anergy not only decreased contact sensitivity to dinitrofluorobenzene but also prolonged survival of skin transplants. In contrast, B-cell reactivity is increased following in vivo injection of MAM, as evidenced by enhanced antibody responses to sheep red blood cells and ovalbumin. Also, there is a marked decrease in the ability of splenocytes from MAM-injected mice to produce interleukin-2 (IL-2) but a marked increase in their ability to produce IL-4 and IL-6. The combined results suggest that MAM induces a lymphokine profile that favors activation of B-cell functions, with a resulting potential for triggering of autoimmune disease.lld:pubmed
pubmed-article:8399909pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:languageenglld:pubmed
pubmed-article:8399909pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:citationSubsetIMlld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8399909pubmed:statusMEDLINElld:pubmed
pubmed-article:8399909pubmed:monthAuglld:pubmed
pubmed-article:8399909pubmed:issn1058-4838lld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:AraneoB ABAlld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:ColeB CBClld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:AhmedEElld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:AtkinC LCLlld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:ShelbyJJlld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:WeiSSlld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:McCallSSlld:pubmed
pubmed-article:8399909pubmed:authorpubmed-author:KamerathCClld:pubmed
pubmed-article:8399909pubmed:issnTypePrintlld:pubmed
pubmed-article:8399909pubmed:volume17 Suppl 1lld:pubmed
pubmed-article:8399909pubmed:ownerNLMlld:pubmed
pubmed-article:8399909pubmed:authorsCompleteYlld:pubmed
pubmed-article:8399909pubmed:paginationS163-9lld:pubmed
pubmed-article:8399909pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:meshHeadingpubmed-meshheading:8399909-...lld:pubmed
pubmed-article:8399909pubmed:year1993lld:pubmed
pubmed-article:8399909pubmed:articleTitleImmunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.lld:pubmed
pubmed-article:8399909pubmed:affiliationDepartment of Internal Medicine, University of Utah School of Medicine, Salt Lake City 84132.lld:pubmed
pubmed-article:8399909pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8399909pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8399909pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8399909lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8399909lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8399909lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8399909lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8399909lld:pubmed